First, gain-of-function mutations of TRPC6 were associated with the onset of familial forms of focal segmental glomerulosclerosis; furthermore, overexpression or overactivity of wild-type TRPC6 was sufficient to cause other kidney diseases [14–16]. The gene discussed is TRPC6; the disease is focal segmental glomerulosclerosis.